SCHEMBL345914

SCHEMBL345914

CCCCOC(=O)CC[C@H](N)C(=O)OCCCC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.49
DGKA P23743 1/20 0.48
HTR2C P28335 1/20 0.47
NAAA Q02083 1/20 0.44
P2RY10 O00398 5/20 0.44
GPR34 Q9UPC5 2/20 0.44
ALDH1A1 P00352 1/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
ATM Q13315 2/20 0.41
DNM1 Q05193 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345916 1.00 NOD1 (0.49) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL1443698 1.00 NOD1 (0.49) NOD1DGKAHTR2CNAAAP2RY10
Hydrochloric Acid SCHEMBL8725903 0.98 NOD1 (0.48) NOD1DGKAHTR2CNAAAP2RY10
Hydrochloric Acid SCHEMBL14719876 0.98 NOD1 (0.48) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL2452768 0.95 NOD1 (0.54) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL30556 0.95 NOD1 (0.54) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL30558 0.95 NOD1 (0.54) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL10535639 0.93 HTR2C (0.57) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL11966748 0.93 HTR2C (0.57) NOD1DGKAHTR2CNAAAP2RY10
SCHEMBL4947876 0.93 HTR2C (0.57) NOD1DGKAHTR2CNAAAP2RY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3936469-A Process for preparing N-carboxylic anhydrides of amino acids KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) 1976-02-03 US claimed
JP-61032801-A None JP disclosed
US-12516017-B2 Application of glutamine derivative in preparation of animal feed additive WISORIG TECHNOLOGIES PTE. LIMITED (SG) 2026-01-06 US disclosed
CN-119280225-A Application of butyl pyroglutamate in preparation of antihypertensive drugs 江西农业大学 2025-01-10 CN disclosed
US-20240270682-A1 APPLICATION OF GLUTAMINE DERIVATIVE IN PREPARATION OF ANIMAL FEED ADDITIVE WISORIG TECHNOLOGIES PTE. LIMITED (SG) 2024-08-15 US disclosed
US-11964929-B2 Application of glutamine derivative in preparation of animal feed additive WISORIG TECHNOLOGIES PTE. LIMITED (SG) 2024-04-23 US disclosed
US-20230201383-A1 PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING RIGSHOSPITALET (DK) 2023-06-29 US disclosed
CN-116283636-A Method for synthesizing Degu insulin side chain 安徽盈科生物科技有限公司 2023-06-23 CN disclosed
CN-110582207-B Application of glutamine derivative in preparation of animal feed additive 广州英赛特生物技术有限公司 2022-11-11 CN disclosed
US-11318121-B2 PSMA binding ligand-linker conjugates and methods for using PURDUE RESEARCH FOUNDATION (US) 2022-05-03 US disclosed
US-4695587-A CHOLESTEROL BIOSYNTHESIS INHIBITORS SANKYO COMPANY LIMITED (JP) 1987-09-22 US disclosed
EP-0218099-A2 Amides of teicoplanin compounds GRUPPO LEPETIT S.p.A. (IT) 1987-04-15 EP disclosed
EP-0189377-A2 An agricultural composition with reduced toxicity to fishes and shellfishes Takeda Chemical Industries, Ltd. (JP) 1986-07-30 EP disclosed
JP-S6132801-A COLOR FILTER AND ITS PRODUCTION MATSUSHITA ELECTRIC IND CO LTD 1986-02-15 JP disclosed
EP-0065835-B1 M-4 AND ISO M-4 DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1985-11-13 EP disclosed
EP-0065843-B1 NEW M-4 AND ISO M-4 DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1985-09-18 EP disclosed
US-4479965-A ANTILIPEMIC, ANTICHOLESTEROL AGENTS SANKYO COMPANY, LIMITED (JP) 1984-10-30 US disclosed
US-4451481-A ANTICHOLESTEROL AGENTS SANKYO COMPANY LIMITED (JP) 1984-05-29 US disclosed
EP-0065843-A1 New M-4 and iso M-4 derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-12-01 EP disclosed
EP-0065835-A1 M-4 and iso M-4 derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240270682-A1 APPLICATION OF GLUTAMINE DERIVATIVE IN PREPARATION OF ANIMAL FEED ADDITIVE GLUL, GATD3, GLS2 NOD1 1631/4885DGKA 1932/4885HTR2C 2412/4885
US-20230201383-A1 PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING KLK3, FOLH1, PSMA7 NOD1 4876/4885DGKA 2795/4885HTR2C 3333/4885
US-11318121-B2 PSMA binding ligand-linker conjugates and methods for using FOLH1, KLK3, PSMA1 NOD1 2935/4885DGKA 2669/4885HTR2C 4029/4885
US-11964929-B2 Application of glutamine derivative in preparation of animal feed additive GLUL, GATD3, GLS NOD1 949/4885DGKA 2482/4885HTR2C 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.